Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

50 results about "Hla genotype" patented technology

Human leukocyte antigen (HLA) genotypes include HLA class I (HLA-A, -C and -B) and class II (HLA-DR, -DQ and -DP). These molecules play an important role in the immune response. The study focused on HLA genotypes as a predisposing factor to ANE based on the fact that the abnormal innate immune reaction was...

Methods and Compositions for Very High Resolution Genotyping of HLA

The invention is a method of determining HLA genotype for HLA-A, HLA-B, HLA-C, DQB1, DRB1, DRB3, DRB4, DRB5, DPA1 and DPB1. Reagents and kits are also disclosed.
Owner:ROCHE MOLECULAR SYST INC

Reagent kit for detecting HBB gene mutation and HLA genotyping

The invention provides a method for detecting HBB gene mutation and HLA genotyping based on the high throughput sequencing technology and a corresponding reagent kit. An adopted primer composition comprises a primer of closely-linked single nucleotide polymorphisms (SNP) within the 1 Mb range of the up stream and the down stream of the specific amplification human embryo beta-thalassemia HBB gene and primers of the closely-linked single nucleotide polymorphisms (SNP) within the ranges at the up stream of the LHA-A gene, between the HLA-A gene and the HLA-B gene, between the HLA-B gene and the HLA-DRA gene, between the HLA-DRA gene and the HLA-DQB1 gene and at the downstream of the HLA-DQB1 gene of the specific amplification human leucocyte antigen system. The method has the advantages of university, single nucleotide polymorphisms (SNP) sequencing, high throughput, low cost, high flexibility and strong specificity.
Owner:海南医学院附属医院 +1

High resolution, high throughput hla genotyping by clonal sequencing

The invention provides methods and reagent for performing full, multi-locus HLA genotyping for multiple individuals in a single sequencing run using clonal sequencing.
Owner:F HOFFMANN LA ROCHE & CO AG

Method for targeted capture and sequencing of HLA gene sequences

The invention relates to the field of biotechnology, and particularly provides a method for targeted capture and sequencing of HLA gene sequences. The method comprises the following steps: 1) hybridizing a denatured nucleic acid sample with a nucleic acid probe library fixed on a solid-phase carrier under a hybridization condition to form a target nucleic acid molecule-probe-solid-phase carrier membrane complex; 2) cleaning the 'probe-solid-phase carrier membrane complex' bound with target nucleic acid in step 1) by using a cleaning solution, eluting the probe-solid-phase carrier membrane complex bound with the target nucleic acid from a solid-phase carrier membrane by using an eluting solution, purifying, enriching or constructing to obtain a nucleic acid library; and 3) taking the nucleic acid library obtained by enrichment or constructed after enrichment in step 2) for high-throughput sequencing. A nucleic acid probe which can rapidly generate high-fold coverage and single-base displacement and is used for enriching HLA genes can be immovably fixed on the solid-phase carrier membrane. The method has characteristics of simplicity and convenience in operation, flexible probe acquisition and low cost, is favorable for improving the HLA genotype identification accuracy, and is rapid and convenient.
Owner:ZHEJIANG UNIV

Kit for detecting HLA genotypes through fluorescent PCR melting curve assay

PendingCN107190088ANo follow-up experiments requiredQuick Results ReferenceMicrobiological testing/measurementOrgan transplantationHLA-B
The invention provides a kit for detecting HLA genotypes through fluorescent PCR melting curve assay. The kit includes HLA-A, HLA-B, HLA-DRB1 and HLA-DQB1 genotypes, amplification is performed by using a 96-pore optical reaction plate containing primers, an amplified dual-strand DNA product is actively bonded through SYBR Green I, the low-resolution genotypes of HLA-A, HLA-B, HLA-DRB1 and HLA-DQB1 are comprehensively judged according to the result of a 96-pore fusion curve, and accordingly diagnosis of the matched types for organ transplantation is assisted.
Owner:DEBIQI BIOTECH XIAMEN

Immunoreaction evaluation method based on tumor neoantigen activity sorting

The invention relates to the technical field of biological information, in particular to an immunoreaction evaluation method based on tumor neoantigen activity sorting. The method comprises the following steps: obtaining genome data of tumor and normal tissues through whole exon sequencing, extracting multi-dimensional features of candidate somatic mutation, and screening by combining a Gaussian mixture model and a Transform model to obtain a high-confidence mutation genome set; predicting the HLA genotype of a patient based on sequencing data, translating and mutating into a peptide fragment, predicting the binding affinity of the peptide fragment and an MHC molecule by using an XGBoost model, and calculating a new antigen activity score sequence in combination with various parameters; and finally, synthesizing a new antigen peptide fragment according to a sorting result, carrying out in-vitro co-culture to detect an IFN-gamma secretion result, and dynamically optimizing a characteristic combination coefficient through a PPO algorithm to realize intelligent iterative updating, so that the accuracy of new antigen screening and the immunoreaction prediction capability are remarkably improved.
Owner:XINYI PHARMACEUTICAL (HANGZHOU) CO LTD

Primers, kit and method for HLA (human leukocyte antigen) genotyping

The invention belongs to the technical field of gene engineering, and discloses a primer combination for HLA (human leukocyte antigen) genotyping, a kit containing the primer combination and a method for HLA genotyping. Thus, the sequence-specific HLA genotyping (GSA-SBT) technique is quick, simple, accurate and visual. The primer combination can be synchronously used for amplification and sequencing with the commercialized kit, thereby lowering the experimentation cost. Besides, the specific design of mismatched bases are introduced to the 3' terminal of the primer, thereby enhancing the specificity of the primer amplification and ensuring the accuracy of the typing result.
Owner:SHANGHAI TISSUEBANK BIOTECH +3

Population scale HLA-typing and uses thereof

The present invention provides a portable system for real-time population-scale HLA genotyping and / or allelotyping in a field environment and methods of such population-scale HLA genotyping. The individual components of the system are portable to and operable within a field environment thereby providing high throughput with real-time geno- or allelotyping. Also provided are HLA gene-specific primers and HLA allele-specific or single nucleotide polymorphism-specific hybridization probes. In addition the present invention provides a microarray comprising the hybridization probes. Further provided is a kit comprising the HLA gene-specific primers and the microarray.
Owner:GENOMICS USA

Tumor neoantigen mutation load detection method and device, equipment and storage medium

PendingCN118969082AExclude the effect of loss of heterozygosityimprove accuracyProteomicsGenomicsSomatic cellCancer research
The invention belongs to the technical field of bioinformatics, and discloses a tumor neoantigen mutation load detection method and device, equipment and a storage medium, and the method comprises the following steps: respectively carrying out original variation detection on a tumor sample and a normal sample to obtain somatic variation, annotating, screening to obtain candidate variation, translating into an amino acid sequence to obtain a plurality of variation peptide fragments, screening out candidate peptide fragments; respectively carrying out HLA genotyping on the tumor sample and the normal sample, and mutually correcting the typing results of the tumor sample and the normal sample to obtain a target HLA genotype; the method comprises the following steps: performing HLA genotyping on a tumor sample and a normal sample at the same time, and mutually correcting HLA genotyping results of the tumor sample and the normal sample, so that the influence of HLA heterozygosity deficiency in the tumor sample can be eliminated, the accuracy of the HLA genotyping results can be improved, and the accuracy of the HLA genotyping results can be improved. Further, the detection accuracy of the subsequent tumor neoantigen mutation load is improved.
Owner:GUANGZHOU KINGMED DIAGNOSTICS GRP CO LTD +1

Method and system for calculating tumor neoantigen load

The invention provides a method and system for calculating tumor neoantigen load. The method comprises the steps: S1, integrating normal and tumor data of a sample, sequencing a specific interval, anddetecting somatic mutation of the sample; S2, annotating and filtering the somatic mutation, and performing translating to obtain a mutant polypeptide sequence of the patient; S3, according to the normal proteome of the sample, filtering the mutant polypeptide sequence to obtain a new polypeptide sequence; and S4, performing human leukocyte antigen typing analysis according to the normal comparison data of the samples to obtain HLA genotypes of the samples; According to the method for calculating the tumor neoantigen load, weight scoring is performed on each predicted neoantigen, and high-quality and low-quality neoantigens can be distinguished by considering different dimension information such as mutation quality, mutation frequency, affinity and the like, so that a numerical value capable of better reflecting the real tumor neoantigen load of the sample is obtained.
Owner:深圳市新合生物医疗科技有限公司

Immune carrier microsphere constructed by individualized MHC-II combined polypeptide, vaccine and application of immune carrier microsphere and vaccine

The invention relates to the technical field of immune carrier microspheres, in particular to an immune carrier microsphere constructed by individualized MHC-II combined polypeptide, a vaccine and application of the immune carrier microsphere and the vaccine. A core comprises microspheres constructed by a plurality of MHC-II binding polypeptides, sequences of the MHC-II binding polypeptides are obtained based on HLA gene typing results of an inoculator, and each HLA gene corresponds to at least one high-affinity MHC-II binding polypeptide; a shell is a glucan with sulfydryl or other polymer coating layer, and sulfydryl is used as a coupling group to be connected with an antigen to construct the vaccine. The method has the advantages that competition is avoided, inhibition is generated, a better immune effect is achieved, antibodies of high-titer carrier molecules are not generated, and cross reaction side effects are avoided. The carrier molecular diversity is reduced; side effects are avoided. And antibody immunity and cellular immunity functions are generated. The particle size of the microspheres is controllable, and the immunologic function can be achieved without adjuvants. The preparation process is simple to operate and good in repeatability.
Owner:SHANGHAI WEIQIU BIOTECH

hla genotype-snp linkage database, its construction method, and hla typing method

ActiveCN103221551BRapid TypingAccurate typingMicrobiological testing/measurementGenomicsTyping methods
The invention belongs to the fields of genomics and bioinformatics, relates to an HLA genotype-SNP linkage database, a construction method thereof, and a HLA typing method. Specifically, the construction method of the HLA genotype-SNP linkage database comprises the following steps: a) selecting one or more HLA loca sequences as a reference sequence; b) comparing the known type HLA genes in a conventional HLA database with the reference sequence to find out a difference site of the reference sequence i.e. a SNP site, and to obtain an SNP linkage relationship relative to the reference sequence for constructing the HLA genotype-SNP linkage database. The present invention also relates to a method for determining SNP linkage relationship of HLA gene, and an HLA typing device. The method of the present invention achieves low-cost, high-throughput, high-accuracy and high-resolution typing for HLA.
Owner:北京六合华大基因科技有限公司

HLA typing method and electronic device thereof

The invention provides an HLA typing method and an electronic device thereof. The method comprises the following steps: S1) comparing sequencing data of each sample gene with an HLA gene database to obtain a first candidate HLA gene typing set; s2, in the first candidate HLA genetic typing set, typing results with the coverage degree smaller than 30% or the average sequencing depth smaller than 30 * are filtered, and a second candidate HLA genetic typing set is obtained; s3) according to the consistency sequence of the corresponding sample gene in each typing result in the second candidate HLA gene typing set, the typing results which are different from the coding region of the corresponding consistency sequence in the coding region of the sample gene are filtered, a final HLA typing result is obtained, and the sample HLA gene is obtained through sequencing of a three-generation sequencing platform.
Owner:ANNOROAD GENE TECHNOLOGY (BEIJING) CO LTD

Method for detecting tumor neoantigen load, computing device and computer storage medium

The invention relates to a method for detecting tumor neoantigen load, computing equipment and a computer storage medium. The method comprises the following steps: acquiring a transcriptome sequence related to a tumor sample, and first comparison result information and splicing site information which are compared with a reference genome; obtaining a whole exome sequence of the paired normal sample and a whole exome sequence of the paired normal sample in second comparison result information compared with the reference genome; generating somatic mutation information based on the first comparison result information and the second comparison result information; determining a specific HLA genotype; generating a first result about the specific neoantigen based on the splicing site information and the specific HLA genotype; generating a second result about the specific neoantigen based on the somatic mutation information and the specific HLA genotype; and generating the tumor neoantigen load of the detected object based on the first result and the second result. According to the invention, the comprehensiveness and reliability of tumor neoantigen load detection can be effectively improved.
Owner:CARRIER GENE TECH SUZHOU CO LTD +1

HLA genotyping method, device, equipment and medium

ActiveCN120148658ABiostatisticsProteomicsFeature vectorNucleotide diversity
The invention relates to an HLA (human leukocyte antigen) genotyping method, device, equipment and medium. The method comprises the following steps: constructing a polymorphic database, and generating an SNP feature matrix of the polymorphic database; obtaining HLA genotype data of a to-be-detected sample, and reconstructing the HLA genotype data of the to-be-detected sample to obtain a feature vector of the to-be-detected sample; two alleles of the same gene locus are obtained from the polymorphism database, all heterozygous combinations of the two alleles are generated, mononucleotide diversity characteristics in all the heterozygous combinations are combined, and an expected characteristic set of all the heterozygous combinations is obtained; comparing the feature vector of the to-be-tested sample with the expected feature set bit by bit, counting mismatch records of data in the feature vector of the to-be-tested sample and the expected feature set, and recording the mismatch number of each heterozygous combination; and determining the heterozygous combination with the minimum mismatch number as an HLA typing result. By adopting the method, genotyping can be efficiently and accurately carried out.
Owner:SUZHOU LASSO BIOCHIP TECH CO LTD +1

Immune carrier microsphere loaded with individualized MHC-II binding polypeptide and vaccine preparation and application thereof

The invention relates to the technical field of immune carriers, in particular to immune carrier microspheres loaded with individualized MHC-II binding polypeptide and vaccine preparation and application of the immune carrier microspheres loaded with the individualized MHC-II binding polypeptide. The core microsphere is loaded with individualized MHC-II binding polypeptide, the sequence of the MHC-II binding polypeptide is obtained by predicting and screening based on an HLA genotyping result, and each HLA allele corresponds to at least one high-affinity MHC-II binding polypeptide; and the shell is a glucan or other polymer coating layer. The preparation method has the advantages that the T epitope and the B epitope are separately subjected to immune competitive inhibition inside and outside the microspheres, so that a better immune effect is obtained. The antibody avoids cross reaction side effects; carrier molecule diversity is reduced, and side effects caused by T cell over-activation are avoided; th1 epitopes and Th2 epitopes can be contained in the microspheres, so that antibody immunity and T cell immunity functions are generated; the particle size of the microspheres is controllable, and the immunologic function can be achieved without adjuvants.
Owner:SHANGHAI WEIQIU BIOTECH

Detection of HLA genotype

Disclosed is a rapid genetic method for detection of HLA genotype based on the loop-mediated isothermal amplification (LAMP) principles, and in particular, disclosed are a method and a kit for detection of HLA-B*1502 allele based on LAMP principles.
Owner:THE CHINESE UNIVERSITY OF HONG KONG +1

HLA genotyping method and device and storage medium

InactiveCN113345516AReduce the problem of low accuracyImprove accuracyProteomicsGenomicsMedicineTyping
The invention discloses an HLA genetic typing method and a device and a storage medium. The method comprises an HLA prediction typing acquisition step, an HLA typing marking step and an HLA typing integration step. According to the HLA genotyping method, the weight scores of the HLA prediction types obtained by different genotyping tools are marked, and the HLA prediction types obtained by the different genotyping tools are integrated according to the weight scores, so that the detection advantages of each genotyping tool can be fully utilized; and the problems of low accuracy of some genetic typing tools and the like caused by factors such as sequencing depth are reduced, so that the accuracy of HLA typing is improved.
Owner:深圳裕泰抗原科技有限公司

hbb gene mutation and hla typing detection kit

The invention provides a method for detecting HBB gene mutation and HLA genotyping based on the high throughput sequencing technology and a corresponding reagent kit. An adopted primer composition comprises a primer of closely-linked single nucleotide polymorphisms (SNP) within the 1 Mb range of the up stream and the down stream of the specific amplification human embryo beta-thalassemia HBB gene and primers of the closely-linked single nucleotide polymorphisms (SNP) within the ranges at the up stream of the LHA-A gene, between the HLA-A gene and the HLA-B gene, between the HLA-B gene and the HLA-DRA gene, between the HLA-DRA gene and the HLA-DQB1 gene and at the downstream of the HLA-DQB1 gene of the specific amplification human leucocyte antigen system. The method has the advantages of university, single nucleotide polymorphisms (SNP) sequencing, high throughput, low cost, high flexibility and strong specificity.
Owner:海南医学院附属医院 +1

Reagent for PCR-SBT method for HLA genotyping

The invention provides a PCR-SBT method for HLA genotyping. Exons 1, 2, 3, 4, 5, 6, 7 of an HLA-A locus, an HLA-B locus and an HLA-C locus are subjected to genotyping. The method comprises the following steps of: (1) preparing human genomic DNA; (2) designing an amplification primer; (3) performing double digestion purification on an amplification product; (4) designing a sequencing primer and performing sequencing PCR on a purification product; (5) purifying a sequencing product by a sodium acetate-ethanol precipitation method and performing capillary electrophoresis sequencing; and (6) performing software analysis on the acquired sequence to determine genotypes thereof. The exons 1, 2, 3, 4, 5, 6, 7 of the HLA-A, B, C loci are subjected to full-length sequence sequencing, so that the full length of the related exons of the HLA-A, B, C loci and part of intron oligonucleotide sequences are obtained and the HLA genotyping is accurately performed.
Owner:浙江省血液中心

Method for allele matching of donor mesenchymal stem cells and receptors

The invention provides a method for allele matching of donor mesenchymal stem cells and a receptor. The method comprises the following steps: S10, separating mesenchymal stem cells from perinatal tissue of a donor; s20, extracting genome DNA (deoxyribonucleic acid) of the mesenchymal stem cells, and performing HLA (human leukocyte antigen) genetic typing; s30, performing HLA (human leukocyte antigen) genetic typing on the DNA of the receptor; s40, performing allele spectrum comparison on the HLA gene of the receptor and the HLA gene of the mesenchymal stem cell, and calculating the matching degree; s50, judging the matching degree of the receptor and the mesenchymal stem cells according to the matching degree; and S60, storing the HLA genotyping result of the mesenchymal stem cells and the matching degree in a database, and establishing a matching library for matching the donor mesenchymal stem cells and the receptor. According to the method, a set of standardized system is established, compatibility evaluation of a donor and a receptor at the allele level is achieved, the immunological rejection risk caused by HLA mismatching is effectively predicted and avoided before treatment, and the in-vivo survival and implantation efficiency of MSCs is improved.
Owner:ZHEJIANG TIANYUAN BIOTECHNOLOGY CO LTD

A hla genotyping method based on a three-generation sequencing platform

The invention discloses an HLA genotyping method based on a three-generation sequencing platform, which comprises the following steps: (1) performing PCR amplification on the HLA gene to be typed; (2) performing three-generation sequencing after the product obtained by PCR is detected to be qualified, Obtain the original data; (3) perform long sequence comparison between the original data and the reference gene sequence; (4) correct the sequencing errors after the comparison; (5) obtain the haplotype sequence by phase separation; (6) type judgment. Compared with the existing HLA genotyping methods, the HLA typing method of the present invention requires less computing resources, fast typing, and high resolution, and is useful for clinical transplant tissue matching, population genetics, anthropology and evolution, etc. Applied and basic research work is of great value.
Owner:BEIJING GRANDOMICS BIOTECH

Method and equipment for identifying HLA gene genetic variation based on NGS data and storage medium

The invention discloses a method and equipment for identifying HLA gene genetic variation based on NGS data and a storage medium. A sequence close to an individual HLA genotype sequence is obtained as a sample HLA gene reference sequence for accurate detection of an HLA SNP genotype, then detected SNP loci have comparability among individuals under a coordinate system through alignment, and the disease-susceptible HLA genetic SNP loci with high research and diagnosis values can be identified more accurately.
Owner:BEIJING HOSPITAL

Method and application for simultaneously detecting TCR (T cell receptor) and HLA (human leukocyte antigen) genotypes

PendingCN113736849ALow parting costImmunoassay assessment goodMicrobiological testing/measurementProteomicsExonImmunome
The invention relates to a method and application for simultaneously detecting TCR (T cell receptor) and HLA (human leukocyte antigen) genotypes, and belongs to the technical field of gene detection. The method comprises the following steps: sample extraction: taking a biological sample to be detected, and extracting DNA in the biological sample; PCR amplification: taking the DNA, adding a TCR amplification primer and an HLA amplification primer at the same time, and amplifying a TCR target region and an HLA target region at the same time, wherein the HLA target region is a second exon region, a third exon region and a fourth exon region of the HLA gene; library construction: taking the amplification product to construct a library; sequencing on a machine: taking the library, and performing high-throughput sequencing on the machine; and data analysis: processing and analyzing the sequencing data to obtain TCR and HLA genotyping conditions. By adopting the method, the HLA-I type gene is amplified by the HLA primer group in the same PCR reaction system to perform typing identification under the condition of not increasing a library building step, and an HLA typing result is provided while TRB information is obtained, so that immune group library information is obtained to evaluate the health status of a sample provider.
Owner:深圳泛因医学有限公司